(HealthDay)—A new study finds that people with moderate to severe ulcerative colitis who haven't done well on other treatments may find relief with Xeljanz (tofacitinib), a drug currently used to treat arthritis.
May 3, 2017
0
68
Scientists have identified two small molecules that could be pursued as potential treatments for chronic inflammatory diseases. According to a paper published in PLOS Computational Biology, the researchers singled out the ...
Apr 20, 2017
0
0
Cannabinoids contain anti-inflammatory properties that could make them useful in the treatment of a wide-range of skin diseases, according to researchers at the University of Colorado Anschutz Medical Campus.
Apr 18, 2017
0
27
(HealthDay)—Chiropractors can help ease some cases of low back pain, though their treatments may be no better than taking an over-the-counter pain reliever, a new analysis finds.
Apr 11, 2017
0
23
The U.S. medical community needs a better understanding of the biology of pain and how it plays out in individuals to be able to combat the national epidemic of addiction to painkillers, according to researchers from the ...
Mar 9, 2017
2
248
Researchers at Cardiff University have discovered that genetic variation is the reason why some immune systems overreact to viruses.
Feb 28, 2017
0
0
The American College of Physicians (ACP) recommends in an evidence-based clinical practice guideline published today in Annals of Internal Medicine that physicians and patients should treat acute or subacute low back pain ...
Feb 13, 2017
0
16
Widely used pain relievers may increase the risk of a heart attack when used during a cold or flu-like illness, according to a new study published in the Journal of Infectious Diseases. The findings suggest physicians and ...
Feb 2, 2017
0
7
A high dietary intake of red meat, particularly of the unprocessed variety, is linked to a heightened risk of developing the common inflammatory bowel condition, diverticulitis, reveals research published online in the journal ...
Jan 9, 2017
0
0
(HealthDay)—For patients beginning warfarin therapy, proton pump inhibitor (PPI) co-therapy is associated with reduced risk of upper gastrointestinal bleeding, according to a study published in the December issue of Gastroenterology.
Dec 23, 2016
0
0
